![Reassessment of the prognostic value of the International Prognostic Index and the revised International Prognostic Index in patients with diffuse large B-cell lymphoma: A multicentre study Reassessment of the prognostic value of the International Prognostic Index and the revised International Prognostic Index in patients with diffuse large B-cell lymphoma: A multicentre study](https://www.spandidos-publications.com/article_images/etm/4/3/ETM-04-03-0475-g00.jpg)
Reassessment of the prognostic value of the International Prognostic Index and the revised International Prognostic Index in patients with diffuse large B-cell lymphoma: A multicentre study
![Revised International Prognostic Index (R-IPI) Is a Better Predictor of Outcome Than the Standard IPI for Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Rituximab and CHOP (R-CHOP). - ScienceDirect Revised International Prognostic Index (R-IPI) Is a Better Predictor of Outcome Than the Standard IPI for Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Rituximab and CHOP (R-CHOP). - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006497119753828-fx1.jpg)
Revised International Prognostic Index (R-IPI) Is a Better Predictor of Outcome Than the Standard IPI for Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Rituximab and CHOP (R-CHOP). - ScienceDirect
![Table 2 from The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP. | Semantic Scholar Table 2 from The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/0ce5e3433e7e5c0a7252094d6a23f65336327517/2-Table1-1.png)
Table 2 from The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP. | Semantic Scholar
![Kyle Bradley, MD on X: "New CLL International Prognostic Index. Modern update to Rai and Binet staging systems. https://t.co/GRXAewz8FF https://t.co/YrIrOG4Ym6" / X Kyle Bradley, MD on X: "New CLL International Prognostic Index. Modern update to Rai and Binet staging systems. https://t.co/GRXAewz8FF https://t.co/YrIrOG4Ym6" / X](https://pbs.twimg.com/media/CnqX1jgWgAAteoZ.jpg)
Kyle Bradley, MD on X: "New CLL International Prognostic Index. Modern update to Rai and Binet staging systems. https://t.co/GRXAewz8FF https://t.co/YrIrOG4Ym6" / X
![Outcome according to the revised International Prognostic Index (R-IPI)... | Download Scientific Diagram Outcome according to the revised International Prognostic Index (R-IPI)... | Download Scientific Diagram](https://www.researchgate.net/publication/233771058/figure/fig2/AS:202771576954897@1425355919991/Outcome-according-to-the-revised-International-Prognostic-Index-R-IPI-for-A.png)
Outcome according to the revised International Prognostic Index (R-IPI)... | Download Scientific Diagram
![Table 3 from An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. | Semantic Scholar Table 3 from An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/5835aee9687d11160fd503ad0ecb876e36789aca/3-Table3-1.png)
Table 3 from An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. | Semantic Scholar
![Prognostic indices in diffuse large B-cell lymphoma: a population-based comparison and validation study of multiple models | Blood Cancer Journal Prognostic indices in diffuse large B-cell lymphoma: a population-based comparison and validation study of multiple models | Blood Cancer Journal](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41408-023-00930-7/MediaObjects/41408_2023_930_Figa_HTML.png)
Prognostic indices in diffuse large B-cell lymphoma: a population-based comparison and validation study of multiple models | Blood Cancer Journal
![Table 1 from ANALYSIS OF PROGNOSTIC FACTORS IN HODGKIN ' S LYMPHOMA WITH REGARD TO RESPONSE TO TREATMENT | Semantic Scholar Table 1 from ANALYSIS OF PROGNOSTIC FACTORS IN HODGKIN ' S LYMPHOMA WITH REGARD TO RESPONSE TO TREATMENT | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/78d05595108cef38c91ed890efd46ddcd1594d2d/2-Table1-1.png)
Table 1 from ANALYSIS OF PROGNOSTIC FACTORS IN HODGKIN ' S LYMPHOMA WITH REGARD TO RESPONSE TO TREATMENT | Semantic Scholar
![Comparison of the prognostic impact of IPI and PIT in peripheral T-cell lymphoma in real-world practice with a large elderly population | Scientific Reports Comparison of the prognostic impact of IPI and PIT in peripheral T-cell lymphoma in real-world practice with a large elderly population | Scientific Reports](https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41598-023-46501-5/MediaObjects/41598_2023_46501_Fig1_HTML.png)